MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02059cam a2200253 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780128018255 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220107t2018 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128018255 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128018125 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Ginsburg, Geoffrey S. |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Genomic and precision medicine: cardiovascular disease |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
3rd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
London : |
| Name of publisher, distributor, etc. |
Academic Press, |
| Date of publication, distribution, etc. |
2018 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xiv, 312 pages):illustrations (chiefly color) |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Family health history and health risk assessment for cardiovascular disease in health care -- Personalized lifestyle medicine -- Lipoprotein disorders -- Metabolic syndrome -- Hypertension -- Novel approaches to cardiovascular diagnostics : focus on coronary artery disease and myocardial infarction -- Hypertrophic cardiomyopathy in the era of genomic medicine -- Genomics to predict risk of coronary artery disease -- Genomics-guided antithrombotic therapy for acute coronary syndromes -- Heart failure : impact of genetics and genomics -- Arrhythmia genomics -- Genetics and genomics of peripheral arterial disease -- Genetic basis of congenital heart disease -- Perioperative genomics -- Genomics of ischemic stroke and prospects for clinical applications -- Cardiovascular pharmacogenetics. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Genomic and Precision Medicine: Cardiovascular Disease, Third Edition, focuses on the applications of genome discovery on the broad spectrum of cardiovascular disorders. Each chapter is organized for the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Cardiovascular system |
| 9 (RLIN) |
5516 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Medical genetics. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Genomics. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Willard, Huntington F. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C2015006899X">https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C2015006899X</a> |